| 1 |
21148250 | Simple, direct, and informative method for the assessment of CYP2C19 enzyme inactivation kinetics. | 2011 Mar |
1 |
| 2 |
18094038 | High-affinity binding of [3H]cimetidine to a heme-containing protein in rat brain. | 2008 Mar |
1 |
| 3 |
15049511 | Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6. | 2004 Feb |
4 |
| 4 |
14640711 | Chip-based P450 drug metabolism coupled to electrospray ionization-mass spectrometry detection. | 2003 Dec 1 |
1 |
| 5 |
12180536 | The N-demethylation of the doxepin isomers is mainly catalyzed by the polymorphic CYP2C19. | 2002 Jul |
1 |
| 6 |
11377023 | High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy: III. Validation of a direct injection/on-line guard cartridge extraction-tandem mass spectrometry method for CYP2C19 inhibition evaluation. | 2001 Jun |
1 |
| 7 |
11128045 | Oxidation of ranitidine by isozymes of flavin-containing monooxygenase and cytochrome P450. | 2000 Oct |
1 |
| 8 |
9931427 | Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5beta-cholestane-3alpha,7alpha,12alpha-triol in human liver microsomes. | 1999 Jan 29 |
1 |
| 9 |
10418968 | Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. | 1999 Jun 1 |
1 |